This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Beone Medicines I Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Fengtao Song
Introduction
Fengtao Song is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications. His work focuses on creating innovative solutions for treating proliferative diseases, including cancer.
Latest Patents
Fengtao Song holds a patent for "Pyrido[2,3-b][1,4]oxazines or tetrahydropyrido[2,3-b][1,4]oxazepines as IAP antagonists." This patent discloses novel 2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine or 1,2,3,4-tetrahydropyrido[2,3-b][1,4]oxazepine derivatives that serve as antagonists of Inhibitors of Apoptosis Proteins (IAPs), also known as Smac mimetics. The use of these antagonists is aimed at inducing or sensitizing cells to apoptotic cell death, providing potential treatment options for various proliferative diseases such as cancer. Fengtao Song has 1 patent to his name.
Career Highlights
Fengtao Song is currently associated with Beone Medicines I GmbH, where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of drug discovery and development.
Collaborations
Fengtao collaborates with notable colleagues, including Jing Li and Zhiwei Wang. Their combined expertise enhances the innovative potential of their research projects.
Conclusion
Fengtao Song's contributions to medicinal chemistry and his innovative patent highlight his commitment to advancing therapeutic options for serious diseases. His work exemplifies the impact of dedicated inventors in the field of healthcare.